| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5256 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2752 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1323 | 2021 |
| Safety and efficacy of NVX-CoV2373 Covid-19 vaccine PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... New England Journal of Medicine 385 (13), 1172-1183, 2021 | 940 | 2021 |
| Neonatal sepsis: an international perspective S Vergnano, M Sharland, P Kazembe, C Mwansambo, PT Heath Archives of Disease in Childhood-Fetal and Neonatal Edition 90 (3), F220-FF224, 2005 | 815 | 2005 |
| Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis KM Edmond, C Kortsalioudaki, S Scott, SJ Schrag, AKM Zaidi, S Cousens, ... The Lancet 379 (9815), 547-556, 2012 | 753 | 2012 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 734 | 2021 |
| Neonatal infections in England: the NeonIN surveillance network S Vergnano, E Menson, N Kennea, N Embleton, AB Russell, T Watts, ... Archives of Disease in Childhood-Fetal and Neonatal Edition 96 (1), F9-F14, 2011 | 648 | 2011 |
| Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 486 | 2021 |
| Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children AC Seale, F Bianchi-Jassir, NJ Russell, M Kohli-Lynch, CJ Tann, J Hall, ... Clinical infectious diseases 65 (suppl_2), S200-S219, 2017 | 448 | 2017 |
| Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses NJ Russell, AC Seale, M O’Driscoll, C O’Sullivan, F Bianchi-Jassir, ... Clinical infectious diseases 65 (suppl_2), S100-S111, 2017 | 446 | 2017 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 424 | 2021 |
| An overview of global GBS epidemiology K Le Doare, PT Heath Vaccine 31, D7-D12, 2013 | 422 | 2013 |
| SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes A Khalil, E Kalafat, C Benlioglu, P O'Brien, E Morris, T Draycott, ... EClinicalMedicine 25, 2020 | 389 | 2020 |
| Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses L Madrid, AC Seale, M Kohli-Lynch, KM Edmond, JE Lawn, PT Heath, ... Clinical infectious diseases 65 (suppl_2), S160-S172, 2017 | 388 | 2017 |
| COVID-19 vaccination during pregnancy: coverage and safety H Blakeway, S Prasad, E Kalafat, PT Heath, SN Ladhani, K Le Doare, ... American journal of obstetrics and gynecology 226 (2), 236. e1-236. e14, 2022 | 384 | 2022 |
| Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization … N Gossger, MD Snape, LM Yu, A Finn, G Bona, S Esposito, N Principi, ... Jama 307 (6), 573-582, 2012 | 367 | 2012 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 364 | 2021 |
| Group B streptococcal disease in UK and Irish infants younger than 90 days PT Heath, G Balfour, AM Weisner, A Efstratiou, TL Lamagni, H Tighe, ... The Lancet 363 (9405), 292-294, 2004 | 351 | 2004 |
| X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease C Booth, KC Gilmour, P Veys, AR Gennery, MA Slatter, H Chapel, ... Blood, The Journal of the American Society of Hematology 117 (1), 53-62, 2011 | 348 | 2011 |
